Tirilazad

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Tirilazad
Tirilazad.svg
Clinical data
ATC code
Identifiers
Synonyms (8S,10S,13S,14S,16R,17S)-17-[2-[4-(2,6-dipyrrolidin-1-ylpyrimidin-4-yl)piperazin-1-yl]acetyl]-10,13,16-trimethyl-6,7,8,12,14,15,16,17-octahydrocyclopenta[a]phenanthren-3-one
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
Chemical and physical data
Formula C38H52N6O2
Molar mass 624.859 g/mol
3D model (Jmol)
 NYesY (what is this?)  (verify)

Tirilazad is a drug that has been proposed to treat acute ischaemic stroke. When tested on animal models, tirilazad protects brain tissue, and reduces brain damage. However, the drug fails to treat, and even worsens a stroke when studied on a human being.[1]

Usage in treatment of stroke[edit]

Tirilazad currently has no usage in the clinical treatment of stroke.

References[edit]

  1. ^ "Tirilazad for acute ischaemic stroke". Retrieved 2007-07-28.